Asterion Cannabis Inc, the medical cannabis group, has named experienced industry executive Amy Stephenson as its chief investment officer.

Stephenson has over 20 years’ experience in capital markets and managing public companies. For 15 years, she was finance chief at public companies focusing on mergers and acquisitions (M&A) and IPO/RTO activities in several industries including cannabis, hemp, mining, oil and gas, agriculture, logistics and healthcare.

READ: Asterion Cannabis and its Australian subsidiary finalizing plans for first phase of $400 million project in Queensland

She was most recently chief financial officer (CFO) of Cura Cannabis Solutions, and has worked for Aurora Cannabis, Lineage Growth, The Green Organic Dutchman and Bedrocan. She was also instrumental in the Tweed merger with Bedrocan to form Canopy Growth, Asterion in a statement.

It noted also that Stephenson has diversified experience with numerous US cannabis companies and multi-state operators) involved in cultivation, extractions and edibles.

"We are very pleased to have Amy join our team. Her track record in the cannabis industry, her abilities, and her knowledge is another integral step moving forward to our IPO," said Stephen Van Deventer, the chairman and CEO of Asterion.

"Amy will lead the preparation of all IPO material and public financings in preparation for the company to go public once the capital markets thrive again."

Stephenson commented: "I am very pleased to join the Asterion team so that I can bring my cannabis experience, from both the US. and Canada, to Australia. I have spent much time in Australia in my early career as a corporate development and M&A analyst."

Contact the author at [email protected]